| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 4e-09 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 6e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |